4
Changes in Ownership
OCULAR THERAPEUTIX, INC Filed Acc 0001104659-21-025787
Options or other derivatives
- President, Ophthalmology & CMO acquired 250,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Goldstein Michael H. · President, Ophthalmology & CMO
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2021-02-17 | Grant or award : show line 1 in the form Stock Option (Right to Buy) | +250,000 | 250,000 | D |
Loading xslF345X03/tm217246d5_4seq1.xml…